Hat mitgewirkt an:
-
Establishing novel tools for studying Hepatitis C virus replication and pathogenesis
-
Targets for Antiviral Therapy of Hepatitis C
-
Investigation of NS3 protease resistance-associated variants and phenotypes for the prediction of treatment response to HCV triple therapy
-
TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus